We have previously shown that ectopic overexpression of retinoic acid receptor (RAR) subtypes a, b and g in human neuroblastoma cells had di erent e ects on growth and retinoid sensitivity. Only overexpressed RARb induced profound growth inhibition in the absence of additional retinoid, and increased retinoid sensitivity. In this study, we measured mRNA expression levels of RARa, b, and g in 50 primary neuroblastoma tumor samples, and found a strong correlation between favorable patient prognosis and high-level RARb expression. Human neuroblastoma cells transfected with a vector expressing RARb demonstrated irreversible growth arrest following a 1 week exposure to all-transretinoic acid, whereas control cells continued to proliferate. In the absence of additional retinoid, RARb transfectants demonstrated a higher proportion of cells in the G 0 /G 1 phase of the cell cycle, increased p21 WAF1/CIP1 expression and speci®c binding to a retinoic acid response element. These were changes which we also observed in control neuroblastoma cells following retinoid treatment. Our data indicate that RARb is an important factor mediating the growth inhibitory e ects of retinoids in neuroblastoma cells. The favorable e ect of high-level RARb expression on prognosis in primary tumor tissue may occur through RARb e ects on p21 expression and consequent G 0 /G 1 cell cycle arrest.